Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

EpigeneticsRx's San Diego County genomic study to reduce post-traumatic stress, suicidal ideation, and depression in combat veterans shows promising outcomes
  • USA - English

The results of the program demonstrated promising results and a strong foundation for further research. All 20 areas of the survey demonstrated improvement within the participants that completed the intake and program exit questionnaires. One of the more notable findings was the significant improvement found in veterans experiencing acute symptoms.


News provided by

EpigeneticsRx

Jan 06, 2021, 19:00 ET

Share this article

Share toX

Share this article

Share toX

SAN DIEGO, Jan. 6, 2021 /PRNewswire-PRWeb/ -- County of San Diego Supervisor Nathan Fletcher, a Marine Corps. combat veteran, supported the effort with a $60,000 Neighborhood Reinvestment Program grant from the County.

Genetic testing allowed providers to leverage genomic science to personalize targeted treatment plans for each veteran. Pre and post testing were completed to evaluate the effectiveness of the personalized interventions. There were several participants that started the program with acute symptoms (scoring 1-3) in depression, anxiety, resilience, stress, feelings of overwhelm and overall quality of life. These participants ended the program with improvements of 100% to 600%.

"We were honored to have the opportunity to collaborate on such a groundbreaking program and observe the results of the program with the various veterans. The results of the program will help medical professionals become more precise in their treatment of post-traumatic stress in veterans and provides feedback on the effectiveness of non-pharmaceutical, non-opioid, non-addicting, treatment solutions." states Deb Hubers Co-Founder of EpigeneticsRx.

The strong rate of reported improvement (100% to 600%) with participants that expressed starting with acute symptoms and in most need of support, provide the foundation for justifying further research be conducted to scale solutions to the veteran community to prevent and address homelessness, suicide, and addiction.

This program leveraged EpigeneticsRx's years of research in functional genomics and provided veterans non-pharmaceutical, non-opioid, non-addicting, treatment solutions that are specifically tailored to each veteran's genetic profile. The study enrolled 30 veterans that received genetic testing, personalized lifestyle coaching, nutritional-based treatment solutions, microcurrent neurofeedback and ongoing genomic counseling.

San Diego-based Cammies & Canines, NeuroGen and EpigeneticsRx conducted the research to help veterans who are struggling with post-traumatic stress by implementing a program that personalizes a nutritional-based treatment protocol directed by a medical-grade genetic test. Only medical-grade nutritional supplements were used for the protocols. Medical students from Bastyr University provided the ongoing health coaching that was supervised by a collaborative panel of San Diego-based Physicians and medical professionals. The protocol was enhanced with microcurrent neuro feedback sessions provided by NeuroGen. The research tapped into San Diego County's strength in genomics, the presence of the country's largest number of post-9/11 veterans, and some of the nation's most respected functional medicine physicians.

About Cammies & Canines
It's our mission to end veteran suicide, veteran homelessness and of course impact the lives of our canine companions. We're a nondenominational, faith-based organization helping veterans by providing sober living transitional housing, structure and discipline, veteran-to-veteran support, canine companionship, and a chance to move from a state of homelessness to being employable living a purpose-driven life again. If you know a veteran in need who can benefit from our help, please let us know. We need your help to keep our mission alive & thriving. We are a 501(c)3 public charity. [email protected] or call (619) 468-6860.

About EpigeneticsRx
EpigeneticsRx's secure platform is a one-stop digital destination to all the tools needed for precise, personalized, prevention based on genetics. We have spent over 6 years creating a solution alongside world-class Physicians, Pharmacists, Geneticists, Labs, Patients and Technologists. Our Precision Healthcare platform provides access to the tools Patients and Providers need to adapt and adopt Precision Healthcare - enabling the creation of a more effective personalized health plan, improving outcomes, lowering the cost of care, and reducing the risk of adverse events. Join the EpigeneticsRx community. Visit http://www.EpigeneticsRx.com and start living an inspired, healthy life.

About NeuroGen Brain Balancing
NeuroGen's focus is on restoring health and improving the quality of the lives of its clients. NeuroGen believes that neurological conditions like depression, anxiety, chronic pain, ADD/ADHD, PTSD, and insomnia all start in the brain. NeuroGen focuses on the root of the problem – NOT the symptoms. Neurogen can help. Discover how NeuroGen can help you get your life back. Our technology is FDA registered. NeuroGen is Veteran owned and supported. https://neurogenbb.com/

Media Contact

Debra Hubers, EpigeneticsRx, +1 858-900-2990, [email protected]

Twitter, Facebook

SOURCE EpigeneticsRx

Related Links

http://www.EpigeneticsRx.com

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.